PropertyValue
?:abstract
  • #COVID19-induced ARDS is partly explained by the presence of microthrombi, motivating the use of thrombolytics This study shows that thrombolytics decrease dead space ventilation in COVID-19 ARDS patients https://bit ly/2GdM44a
is ?:annotates of
?:creator
?:journal
  • ERJ_Open_Res
?:license
  • unk
?:publication_isRelatedTo_Disease
is ?:relation_isRelatedTo_publication of
?:source
  • WHO
?:title
  • Observational study of the use of recombinant tissue-type plasminogen activator in COVID-19 shows a decrease in physiological dead space
?:type
?:who_covidence_id
  • #845497
?:year
  • 2020

Metadata

Anon_0  
expand all